
Selank
Synthetic Heptapeptide
- Form
- Lyophilized powder
- Storage
- -20°C (lyophilized)
- Origin
- USA lab
from$59
Selank is a synthetic heptapeptide reference material used in laboratory investigations of neuropeptide signaling and stress-response pathways.
- Neuropeptide-signaling research
- Stress-response pathway models
- In-vitro cognition-signaling studies
SKU: AP-SELANK-5MG
3 vial minimum per order — mix any products
Research Use Only
All products are intended solely for laboratory research and are not for human or animal consumption. By purchasing, the buyer agrees to use these products in compliance with all applicable laws.
Reconstitution ReferenceOptional — how strong is the mixed vial?
Mixing a powder vial with water? Fill in the fields — results update as you type.
Mixing 5 mg of peptide into 2 mL of water makes a 2.5 mg/mL solution. Each 0.1 mL contains 0.25 mg.
Reference for in-vitro laboratory handling only. Outputs describe the physical properties of the reconstituted vial (concentration and mass drawn) — they are not dosing guidance, administration instructions, or medical advice. Verify all measurements independently.
The science behind Selank
A structured overview of the published literature surrounding Selank as a synthetic neuropeptide research compound.
Selank is a synthetic heptapeptide derived from the immunomodulatory peptide tuftsin, developed as a stable analog for neuropeptide-signaling research. It is studied as a reference material for anxiolytic- and cognition-signaling models.
The peptide appears in preclinical neuropharmacology literature, largely from research groups studying stress-response and neuroimmune signaling.
The material supplied here is a laboratory reference standard, and the summaries below describe only findings reported in published research.
Selank was synthesized from the tuftsin sequence with a stabilizing C-terminal extension to prolong activity in experimental systems. It was developed within Russian neuropeptide research programs.
The literature is predominantly preclinical and rodent-based, examining anxiety- and cognition-related signaling. Independent replication and human evidence remain limited.
The mechanisms studied include reported modulation of GABAergic and serotonergic signaling and effects on brain-derived neurotrophic factor (BDNF) expression in preclinical models.
Selank has also been examined for reported effects on enkephalin degradation and neuroimmune signaling — exploratory laboratory observations.
Anxiolytic models
Referenced in rodent behavioral-signaling studies.
Neurotransmitter signaling
Examined in GABAergic and serotonergic models.
BDNF & neurotrophic research
Studied for reported neurotrophic-signaling effects in vitro.
Neuroimmune systems
Explored via its tuftsin-derived immunomodulatory lineage.
What is Selank?
A synthetic heptapeptide (tuftsin analog) supplied as a laboratory reference material for neuropeptide-signaling research.
What kind of research references Selank?
Predominantly preclinical rodent models of anxiety- and cognition-related signaling; human evidence remains limited.
Is Selank approved for human or veterinary use?
No. Selank is not approved by the FDA or any regulatory authority for human or animal use. It is sold exclusively for in-vitro and laboratory research and is not for consumption.
How is the reference material characterized?
Each released lot is supplied as a lyophilized powder with a lot-specific certificate of analysis reporting HPLC purity of ≥ 99%. The certificate is tied to the specific released lot.
How should the compound be stored?
Lyophilized material is typically stored at -20°C, protected from light and moisture. Handling should follow standard laboratory practice for peptide reference materials. We do not provide reconstitution, dosing, or administration guidance.
- Zozulya AA, et al. Efficacy and safety of Selank in anxiety research. (preclinical/clinical literature).
- Kolomin T, et al. Selank and gene-expression modulation in the brain. (review).
Links open a curated peer-reviewed search on PubMed. Allpointe Bio Research is not affiliated with the cited authors or publishers.
Research-Use Statement
The information above is provided for educational and scientific-reference purposes only and summarizes findings reported in the published preclinical and in-vitro literature. It is not medical advice and does not describe outcomes, benefits, or applications for humans or animals. Selank is supplied strictly as a laboratory reference material for in-vitro and research use only — it is not a drug or supplement, is not approved for human or veterinary use, and is not for consumption. Allpointe Bio Research does not provide clinical, dosing, reconstitution, or administration guidance.